Schizophrenia research

Keyphrases

Publications

volume 262, 2023

Britta Hahn, Elie S Holzel
Nicotine insensitivity and cue-controlled smoking behavior in people with schizophrenia. Schizophrenia research 262 (2023)
Shaun M Eack, Jessica A Wojtalik, Matcheri S Keshavan
Anticholinergic medications in the treatment of psychoses: Pharmacological subtraction is better than addition. Schizophrenia research 262 (2023)
Elisabetta C Del Re, Matcheri S Keshavan
Childhood trauma and psychosis-Searching for causes and mechanisms. Schizophrenia research 262 (2023)
Julie M E Clauss-Kobayashi, Christian Bonah, Anne Danion-Grilliat, Marianna Scarfone, Jack R Foucher, Fabrice Berna
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept. Schizophrenia research 262 (2023)
Shuqi Xu, Liang Xu
Childhood emotional maltreatment increases the "wear-and-tear" of physiological systems, especially neuroendocrine changes in schizophrenia. Schizophrenia research 262 (2023)
Julie Perrine Schaug, Ole Jakob Storebø, Marlene Buch Pedersen, Ulrik Helt Haahr, Erik Simonsen
How first-episode psychosis patients' subjective beliefs about their childhood trauma's causal effect provide support for potential schizophrenia subtypes. Schizophrenia research 262 (2023)
Amanda L Neil, Katherine J Chappell, Adriana G Nevarez-Flores, Anna Waterreus, Taryn L Ambrosi, Vera A Morgan
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder. Schizophrenia research 262 (2023)
Xiaoqian Fu, Ancha Baranova, Hongbao Cao, Yansong Liu, Jing Sun, Fuquan Zhang
miR-9-5p deficiency contributes to schizophrenia. Schizophrenia research 262 (2023)
Yu-Tung Tien, Liang-Jen Wang, Yu Lee, Pao-Yen Lin, Chi-Fa Hung, Mian-Yoon Chong, Yu-Chi Huang
Comparative predictive efficacy of atherogenic indices on metabolic syndrome in patients with schizophrenia. Schizophrenia research 262 (2023)
Tom Burke, Laurena Holleran, David Mothersill, James Lyons, Nathan O'Rourke, Christina Gleeson, Dara M Cannon, Declan P McKernan, Derek W Morris, John P Kelly, Brian Hallahan, Colm McDonald, Gary Donohoe
Bilateral anterior corona radiata microstructure organisation relates to impaired social cognition in schizophrenia. Schizophrenia research 262 (2023)
Xue Wu, Huaixuan Ao, Xiaoyong Wu, Yunfeng Cao
Sulfur-containing amino acids and risk of schizophrenia. Schizophrenia research 262 (2023)
Hans Oh, Juliann Li Verdugo, Nicole R Karcher, Els van der Ven, Ai Koyanagi, Lee Smith, Jordan E DeVylder
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life. Schizophrenia research 262 (2023)
Max Berg, Annika Clamor, Winfried Rief, Tania Lincoln
Short-term intake of amisulpride does not alter psychobiological stress responses. A randomized, double-blind, placebo-controlled paradigm using a standardized stressor. Schizophrenia research 262 (2023)
Wen Tang, Li-Juan Zhou, Wan-Qing Zhang, Yi-Jie Jia, Fei-Hong Hu, Hong-Lin Chen
Adverse perinatal pregnancy outcomes in women with schizophrenia: A systematic review and meta-analysis. Schizophrenia research 262 (2023)
Aubrey M Moe, Melissa F V Kilicoglu, Kaley Angers, Kexin Huang, Nicholas J K Breitborde
Coordinated specialty care for first-episode psychosis: Effects on social motivation and social pleasure. Schizophrenia research 262 (2023)
Kimberly Clinebell, Jane Thomas, Melanie Yabs, K N Roy Chengappa
Longitudinal observations of the severity of COVID-19 infection and its impact on clozapine/norclozapine levels and clozapine toxicity in patients experiencing multiple episodes. Schizophrenia research 262 (2023)
Kazumasa Kotake, Satoru Mitsuboshi, Tomonari Hosokawa, Naoya Kitamura, Yasuhiro Kawakami
Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System. Schizophrenia research 262 (2023)
Thanh P Le, Michael F Green, Jonathan K Wynn, Julio E Iglesias, Richard L Franco, Alex Kopelowicz, Robert S Kern
Effort-based decision-making as a determinant of supported employment outcomes in psychotic disorders. Schizophrenia research 262 (2023)
Xiaoqi Sun, Jingyi Zhong
The dimensionality of perceptual anomalies and their relationships with bullying victimization among Chinese adolescents: From a network perspective. Schizophrenia research 262 (2023)
Lauren M Hall, Alexandra B Moussa-Tooks, Allen J Bailey, Julia M Sheffield
Examining delusional ideation: Relationships with race and socioeconomic status. Schizophrenia research 262 (2023)
Houda El Kirat, Asmaa Khattabi, Mohammed Khalis, Zakaria Belrhiti
Effects of physical activity and nutrient supplementation on symptoms and well-being of schizophrenia patients: An umbrella review. Schizophrenia research 262 (2023)
Kirstie J M O'Hare, Richard J Linscott
Measurement invariance of brief forms of the Schizotypal Personality Questionnaire across convenience versus random samples. Schizophrenia research 262 (2023)
Carmen F M van Hooijdonk, Marieke van der Pluijm, Bart M de Vries, Matthijs Cysouw, Behrooz Z Alizadeh, Claudia J P Simons, Therese A M J van Amelsvoort, Jan Booij, Jean-Paul Selten, Lieuwe de Haan, Frederike Schirmbeck, Elsmarieke van de Giessen
The association between clinical, sociodemographic, familial, and environmental factors and treatment resistance in schizophrenia: A machine-learning-based approach. Schizophrenia research 262 (2023)
Laura A Steenhuis, Tim Harms, Maaike H Nauta, Agna A Bartels-Velthuis, Casper J Albers, André Aleman, Maarten Vos, Gerdina H M Pijnenborg, David van den Berg, Eline C Palstra, Johanna T W Wigman, Sanne H Booij
The dynamics of social activation and suspiciousness in individuals at ultra-high risk for psychosis. Schizophrenia research 262 (2023)
Hans Oh, Nicole R Karcher, Jason Schiffman, Deidre M Anglin, Ai Koyanagi, Michelle R Munson, Jordan E DeVylder
A broader conceptualization of premorbid risk in psychoses can motivate primordial prevention. Schizophrenia research 262 (2023)
Joshua M Baruth, Daniel R Bateman, Richard J Kovacs, Pantila V Bateman, Vanessa M Pazdernik, Wil L Santivasi, Shannon M Dunlay, Maria I Lapid
Cardiac healthcare disparities and electrocardiography (ECG) differences in schizophrenia at end of life. Schizophrenia research 262 (2023)
Alexandra Stainton, Nicholas Cheng, Shayden Bryce, Alex Dalton, Angelica Ojinnaka, Isabel Zbukvic, Aswin Ratheesh, Chris O'Halloran, Jacquie Uren, Jesse Gates, Rothanthi Daglas-Georgiou, Stephen J Wood, Kelly Allott
Cognition is a treatment priority for young people with psychosis: Findings from the Your Mind, Your Choice survey. Schizophrenia research 262 (2023)
Millie Rincón-Cortés, Anthony A Grace
Sex-dependent emergence of prepubertal social dysfunction and augmented dopamine activity in a neurodevelopmental rodent model relevant for schizophrenia. Schizophrenia research 262 (2023)

volume 261, 2023

Megan Thomas, Sarah Whittle, Ye E Tian, Tamsyn E van Rheenen, Andrew Zalesky, Vanessa L Cropley
Pathways from threat exposure to psychotic symptoms in youth: The role of emotion recognition bias and brain structure. Schizophrenia research 261 (2023)
Steffen Zitzmann, Christoph Lindner, Claudia Leucht, Stefan Leucht
A potential issue with PANSS responder analysis. Schizophrenia research 261 (2023)
Eva Rogers, Mark Gresswell, Simon Durrant
The relationship between sleep and suicidality in schizophrenia spectrum and other psychotic disorders: A systematic review. Schizophrenia research 261 (2023)
Clare Howie, Mark Shevlin, Ciarán Shannon, Gavin Davidson, Lisa Bunting, Anne Grant, Orla McBride, Claire McCartan, Jamie Murphy, Emma Nolan, Dirk Schubotz, Ciaran Mulholland
The structure of the Prodromal Questionnaire-16 (PQ-16) in a non-help-seeking youth population: Exploratory and confirmatory factor analyses study. Schizophrenia research 261 (2023)
Blanca Fernández-Abascal, Marta Suárez-Pinilla, Carlos Cobo-Corrales, Benedicto Crespo-Facorro, Paula Suárez-Pinilla
Lifestyle intervention based on exercise and behavioural counselling and its effect on physical and psychological health in outpatients with schizophrenia spectrum disorders. An exploratory, pragmatic randomized clinical trial. Schizophrenia research 261 (2023)
Marissa Wilson, Michael Harris, Marco Pereira, Jessica Buckle, Emily Forshall, Titus Murphy, Andrew Thompson, Gail Kavanagh, Richard Whale
Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study. Schizophrenia research 261 (2023)
Mohsen Poorganji, Katharina Goeke, Reza Zomorrodi, Daphne Voineskos, Tarek K Rajji, Zafiris J Daskalakis, Daniel M Blumberger
The use of theta burst stimulation in patients with schizophrenia - A systematic review. Schizophrenia research 261 (2023)
Olajumoke M Ologundudu, Lena Palaniyappan, Lauren E Cipriano, Ben F M Wijnen, Kelly K Anderson, Shehzad Ali
Risk stratification for treating people at ultra-high risk for psychosis: A cost-effectiveness analysis. Schizophrenia research 261 (2023)
Lijuan Huo, Diyang Qu, Chenran Pei, Weibin Wu, Yuping Ning, Yongjie Zhou, Xiang Yang Zhang
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms. Schizophrenia research 261 (2023)
Synve Hoffart Lunding, Torill Ueland, Monica Aas, Margrethe Collier Høegh, Maren Caroline Frogner Werner, Linn Rødevand, Ingrid Torp Johansen, Gabriela Hjell, Monica Bettina Elkjær Greenwood Ormerod, Petter Andreas Ringen, Akiah Ottesen, Trine Vik Lagerberg, Ingrid Melle, Ole A Andreassen, Carmen Simonsen, Nils Eiel Steen
Tobacco smoking related to childhood trauma mediated by cognitive control and impulsiveness in severe mental disorders. Schizophrenia research 261 (2023)
William S Stone, Michael R Phillips, Lawrence H Yang, Lawrence S Kegeles, Jeffrey A Lieberman
Is schizophrenia neurodevelopmental, neurodegenerative or something else: A reply to Murray et al. (2022). Schizophrenia research 261 (2023)
Brandon A Gaudiano, Stacy Ellenberg, Jennifer E Johnson, Kim T Mueser, Ivan W Miller
Effectiveness of acceptance and commitment therapy for inpatients with psychosis: Implementation feasibility and acceptability from a pilot randomized controlled trial. Schizophrenia research 261 (2023)
Maxim Kuzin, Carla Boeglin, Georgios Schoretsanitis, Manjinder Pannu, Wolfram Kawohl, Franziskos Xepapadakos
Letter to the editor: Clozapine plasma levels under co-medication with fluvoxamine during COVID-19 infection: A case report. Schizophrenia research 261 (2023)
Atle Bråthen Pentz, Clara Maria Fides Timpe, Elizabeth Marie Normann, Nora Berz Slapø, Ingrid Melle, Trine Vik Lagerberg, Nils Eiel Steen, Lars T Westlye, Erik G Jönsson, Unn K Haukvik, Torgeir Moberget, Ole A Andreassen, Torbjørn Elvsåshagen
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity. Schizophrenia research 261 (2023)
Wei Qi, Zhenfu Wen, Jingyun Chen, Gillian Capichioni, Fumika Ando, Zhe Sage Chen, Jijun Wang, Yuliya Yoncheva, Francisco X Castellanos, Mohammed Milad, Donald C Goff
Aberrant resting-state functional connectivity of the globus pallidus interna in first-episode schizophrenia. Schizophrenia research 261 (2023)
Stefano Damiani, Cristina Zarbo, Maciej Stolarski, Manuel Zamparini, Letizia Casiraghi, Matteo Rocchetti, Fabrizio Starace, Paolo Fusar-Poli, Giovanni de Girolamo, null null
Time will tell: Associations between unbalanced time perspectives and symptom severity in individuals with schizophrenia spectrum disorders. Schizophrenia research 261 (2023)
Barbara Jakubowicz, Axel Baptista, Aimé Ravel, Cécile Cieuta, Clotilde Mircher, David Cohen, Angèle Consoli, Marie Raffin
Catatonia in Down's syndrome: An under-recognized syndrome during regression. Schizophrenia research 261 (2023)
Luyu Zhang, Sydney H James, Gregory P Strauss
Environmental resource reductions predict greater severity of negative symptoms in schizophrenia. Schizophrenia research 261 (2023)
Yichen Xue, Matthew Lewis, John Furler, Anna Waterreus, Elise Dettmann, Victoria J Palmer
A scoping review of cardiovascular risk factor screening rates in general or family practice attendees living with severe mental ill-health. Schizophrenia research 261 (2023)
Nazanin Vaziri, Diogo Marques, Steven C Greenway, Chad A Bousman
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review. Schizophrenia research 261 (2023)
Kentaro Matsui, Kenichi Kuriyama, Takuya Yoshiike, Aoi Kawamura, Kentaro Nagao, Muneto Izuhara, Megumi Hazumi, Ken Inada, Katsuji Nishimura
Relapse of schizophrenia associated with comorbid delayed sleep-wake phase disorder but not with evening chronotype. Schizophrenia research 261 (2023)
R Sud, A Banerjee, B Viswanath, M Purushottam, S Jain
Non-synaptic mechanisms of antipsychotics may be key to their actions. Schizophrenia research 261 (2023)